339 related articles for article (PubMed ID: 19754386)
21. Distinct parts of leukotriene C(4) synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein.
Strid T; Svartz J; Franck N; Hallin E; Ingelsson B; Söderström M; Hammarström S
Biochem Biophys Res Commun; 2009 Apr; 381(4):518-22. PubMed ID: 19233132
[TBL] [Abstract][Full Text] [Related]
22. Structures and mechanisms of enzymes in the leukotriene cascade.
Rinaldo-Matthis A; Haeggström JZ
Biochimie; 2010 Jun; 92(6):676-81. PubMed ID: 20097252
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.
Di Gennaro A; Wågsäter D; Mäyränpää MI; Gabrielsen A; Swedenborg J; Hamsten A; Samuelsson B; Eriksson P; Haeggström JZ
Proc Natl Acad Sci U S A; 2010 Dec; 107(49):21093-7. PubMed ID: 21078989
[TBL] [Abstract][Full Text] [Related]
24. [Effect of alpha-tocopherol, tocopheryl quinone and other complexes with tocopherol-binding proteins on the activity of enzymes metabolizing arachidonic acid].
Parkhomets' VP; Silonov SB; Donchenko HV
Ukr Biokhim Zh (1999); 2001; 73(1):43-7. PubMed ID: 11599425
[TBL] [Abstract][Full Text] [Related]
25. Regulation of leukotriene-biosynthetic enzymes during differentiation of myelocytic HL-60 cells to eosinophilic or neutrophilic cells.
Scoggan KA; Nicholson DW; Ford-Hutchinson AW
Eur J Biochem; 1996 Aug; 239(3):572-8. PubMed ID: 8774699
[TBL] [Abstract][Full Text] [Related]
26. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
[TBL] [Abstract][Full Text] [Related]
27. Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.
Mirshafiey A; Jadidi-Niaragh F
Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):219-27. PubMed ID: 20298145
[TBL] [Abstract][Full Text] [Related]
28. [Modulation of leukotriene pathway - potential targets].
Peter H; Lýdia B
Ceska Slov Farm; 2012 Jun; 61(3):101-6. PubMed ID: 22913825
[TBL] [Abstract][Full Text] [Related]
29. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
Surette ME; Krump E; Picard S; Borgeat P
Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413
[TBL] [Abstract][Full Text] [Related]
30. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages.
Coffey MJ; Wilcoxen SE; Peters-Golden M
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076
[TBL] [Abstract][Full Text] [Related]
31. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
32. Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population.
Li Y; Xu X; Zhang D; Cheng W; Zhang Y; Yu B; Zhang Y
Lipids Health Dis; 2019 Jan; 18(1):25. PubMed ID: 30678701
[TBL] [Abstract][Full Text] [Related]
33. Leukotrienes mediate 5-hydroxytryptamine-induced plasma extravasation in the rat knee joint via CysLT-type receptors.
Wang Y; Mitchell J; Sharma M; Gabriel A; Moriyama K; Palmer PP
Inflamm Res; 2004 Feb; 53(2):66-71. PubMed ID: 15021971
[TBL] [Abstract][Full Text] [Related]
34. Red-kerneled rice proanthocyanidin inhibits arachidonate 5-lipoxygenase and decreases psoriasis-like skin inflammation.
Toda K; Tsukayama I; Nagasaki Y; Konoike Y; Tamenobu A; Ganeko N; Ito H; Kawakami Y; Takahashi Y; Miki Y; Yamamoto K; Murakami M; Suzuki-Yamamoto T
Arch Biochem Biophys; 2020 Aug; 689():108307. PubMed ID: 32112739
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.
Bruno F; Spaziano G; Liparulo A; Roviezzo F; Nabavi SM; Sureda A; Filosa R; D'Agostino B
Eur J Med Chem; 2018 Jun; 153():65-72. PubMed ID: 29133059
[TBL] [Abstract][Full Text] [Related]
36. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.
Ford-Hutchinson AW
Trends Pharmacol Sci; 1991 Feb; 12(2):68-70. PubMed ID: 2024291
[TBL] [Abstract][Full Text] [Related]
37. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade.
Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR
J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107
[TBL] [Abstract][Full Text] [Related]
38. Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis.
Monteiro AP; Soledade E; Pinheiro CS; Dellatorre-Teixeira L; Oliveira GP; Oliveira MG; Peters-Golden M; Rocco PR; Benjamim CF; Canetti C
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):87-95. PubMed ID: 23947598
[TBL] [Abstract][Full Text] [Related]
39. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.
Gür ZT; Çalışkan B; Banoglu E
Eur J Med Chem; 2018 Jun; 153():34-48. PubMed ID: 28784429
[TBL] [Abstract][Full Text] [Related]
40. 5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1.
Lee JM; Park H; Noh AL; Kang JH; Chen L; Zheng T; Lee J; Ji SY; Jang CY; Shin CS; Ha H; Lee ZH; Park HY; Lee DS; Yim M
J Immunol; 2012 Dec; 189(11):5284-92. PubMed ID: 23109727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
